首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(44-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat
【2h】

Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(44-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat

机译:大鼠GABA吸收阻滞剂N-(44-二-(3-甲基噻吩-2-基)丁-3-烯基)乳酸的R和S异构体的立体选择性中枢神经系统作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">The ‘effect compartment' model was applied to characterize the pharmacodynamics of the R- and S-isomers of tiagabine in conscious rats in vivo using increase in the β activity of the EEG as a pharmacodynamic endpoint.No pharmacokinetic differences in plasma were observed between R- and S-tiagabine. The values for clearance and volume of distribution at steady-state were 103±10 versus 90±6 ml min−1 kg−1 and 1.8±0.2 versus 1.6±0.2 l kg−1 for the R- and S-isomer, respectively. In contrast, plasma protein binding showed a statistically significant difference with values of the free fraction of 5.7±0.5 and 11.4±0.6%. In addition the rate constant for transport to the effect compartment was also different with values of 0.027 versus 0.067 min−1.For both isomers the relationship between concentration and EEG effect was non-linear and successfully characterized on basis of the Hill equation. A statistically significant difference in the value of EC50 of 328±11 versus 604±18 ng ml−1 was observed for R- and S-tiagabine respectively. The values of the other pharmacodynamic parameters were identical.It is concluded that the differences in in vivo pharmacodynamics of R- and S-tiagabine can be explained by stereoselective differences in both the affinity to the GABA-uptake transporter and the degree of non-specific protein binding in plasma and at the effect site.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 应用“效应区室”模型,以脑电图的β活性增加作为药效学终点,来表征替加宾碱在清醒大鼠体内的R和S异构体的药效学。 无药代动力学R-和S-替加滨之间的血浆存在差异。稳态下的清除率和分布量分别为103±10和90±6 ml min -1 kg -1 和1.8±0.2对1.6±0.2 l R和S异构体分别为kg -1 。相反,血浆蛋白结合表现出统计学上的显着差异,其游离部分的值分别为5.7±0.5和11.4±0.6%。此外,运到效应区的速率常数也不同,分别为0.027和0.067 min -1 对于两种异构体,浓度和EEG效应之间的关系均不相同。 -线性,并成功基于Hill方程进行了表征。 R-和S-替加宾碱的EC50值分别为328±11和604±18ngngml -1 ,具有统计学意义。结论 结论是,R-和S-替加宾的体内药效学差异可以通过对GABA摄取转运蛋白的亲和力的立体选择性差异来解释。血浆和效应部位的非特异性蛋白结合程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号